Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers,
Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician.
Initial chapters focus on agents that are considered standard care:
- diuretics
- ACE inhibitors
- angiotensin receptor antagonists
- aldosterone antagonists
- beta-blockers
The discussion moves to agents currently under investigation:
- Vasopressin antagonists
- erythropoietin
Next, the authors consider some controversial drugs:
- inotropic agents
- antiarrhythmic drugs
- anticoagulants
&ll“+